Rejuve Token Prijs
RJVRang 3039
Rejuve Token (RJV) Prijs Live Grafiek
De prijs van Rejuve Token (RJV) is vandaag $0.000992, met een 24-uurs handelsvolume van $4.86K. Hierdoor heeft Rejuve Token (RJV) een marktkapitalisatie van $531.53K, wat neerkomt op een marktdominantie van 0.000036%. De prijs van Rejuve Token (RJV) is de afgelopen 24 uur met -3.31% veranderd.
RJV Prijsgegevens
- 24u Omzet$4.86K
- All Time High (ATH)$0.1436
- 24u hoog$0.001052
- All-Time Low (ATL)$0.0009866
- 24u Laag$0.000985
RJV Marktkapitalisatie-info
- Marktkapitalisatie$531.53K
- Volledig verwaterde waardering$992K
- Marktkapitalisatie/FDV53.58%
- MarktsentimentNeutraal
RJV Aanbod
- Circulerend aanbod535.82M RJV
- Totale voorraad1B RJV
- Maximale voorraad1B RJV
*Gegevens zijn alleen ter referentie
Rejuve Token(RJV) wordt voorspeld gemiddeld $0.000992 te zijn in 2026, met een mogelijke schommeling tussen de laagste prijs $0.0007737 en de hoogste prijs $0.001021. Tegen 2031 kan de prijs van Rejuve Token(RJV) oplopen tot $0.00253, wat een potentieel rendement van +71.00% biedt ten opzichte van de huidige Rejuve Token-prijs.
Jaar | Minimale prijs | Hoogste prijs | Gemiddelde prijs | Verandering |
|---|---|---|---|---|
2026 | $0.0007737 | $0.001021 | $0.000992 | -- |
2027 | $0.0008759 | $0.001198 | $0.001006 | +1.00% |
2028 | $0.001036 | $0.001477 | $0.001102 | +11.00% |
2029 | $0.0007868 | $0.001651 | $0.001289 | +30.00% |
2030 | $0.0008088 | $0.001926 | $0.00147 | +48.00% |
2031 | $0.001341 | $0.00253 | $0.001698 | +71.00% |
De prijs van Rejuve Token(RJV) is de afgelopen 24 uur met -3.31% bewogen, en met -6.06% in de afgelopen 7 dagen. De prijs van Rejuve Token(RJV) is -24.62% in de afgelopen 30 dagen, en -85.44% over het afgelopen jaar.
Tijdsperiode | Bedrag wijzigen | % Verandering |
|---|---|---|
1H | -$0.0000009929 | -0.1% |
24H | -$0.00003395 | -3.31% |
7D | -$0.00006399 | -6.06% |
30D | -$0.0003239 | -24.62% |
1Y | -$0.005821 | -85.44% |
Over Rejuve Token (RJV)
Contract
0xa1f410f...8d47bc5ef
Verkenners
etherscan.io
Website
rejuve.ai
Community
Rejuve. AI is a distributed, artificial intelligence driven longevity research network that allows people from around the world to access their health data, obtain valuable analysis, use their health data to contribute to cutting-edge longevity research, and receive token rewards in the process.
Rejuve Token (RJV) teamleden
Jasmine SmithCEO
Deborah DuongCTO
Ben GoertzelChief AI Scientist
- GateNewsGate News message, April 23 — Zhipu (02513.HK) surged over 5% at market open, reaching a new all-time high. The stock has gained nearly 800% since its listing.
- GateNewsGate News message, April 23 — Gold prices fell to $4,731.95 per ounce with a daily decline of 0.18%, while silver dropped to $77.585 per ounce, down 0.13% intraday. Bitcoin volatility index (BVIX) stood at 43.64, declining 1.80%, and Ethereum volatility index (EVIX) reached 63.90, down 5.19%. In
- GateNewsGate News message, April 23 — Iran's permanent representative to the United Nations, Iravani, sent a letter to UN Secretary-General Guterres and the Security Council on April 23, lodging a strong protest against the United States for utilizing the territory and airspace of Qatar, Kuwait, Bahrain, th
- GateNewsGate News message, April 23 — Jack Yi, founder of Liquid Capital, shared on X that past crypto VC and project failures were largely driven by teams wasting capital developing unnecessary Web3 products by incorrectly benchmarking against Web2. Yi argued that Web3 is fundamentally a financial
- GateNewsFTX's unliquidated stake values would total about $114B today, with Anthropic $82.3B, SpaceX $15B, Solana $5.1B, Cursor $3B, Robinhood $4.9B, and Genesis Digital $3.5B, per Cointelegraph. Abstract: If the FTX bankruptcy estate had retained its stakes, it would hold roughly $114 billion in assets, le...
- GateNewsGate News message, April 23 — Three major developments in crypto mining and digital asset infrastructure unfolded on April 22. HIVE Digital Technologies Ltd. (NASDAQ/TSX-V: HIVE) completed a $115 million private placement of 0% convertible preferred notes, with full exercise of underwriters' over-a